Rare diseases
Investigational molecules
Locations
Aleja Niepodległości 779/1, 81-805 Sopot, Poland
Nordica Medica Sp. z o.o in Sopot, Poland specialises in clinical trials of conditions such as Coronary artery disease, Embolism venous, and other specialisations. This site conducts important research.
The site concentrates on cardiovascular diseases. Key conditions include coronary artery disease. Another focus is venous thromboembolism. Studies aim to assess the safety and effectiveness of new therapies. Research evaluates the pharmacodynamic impact on clotting pathways. The work seeks to improve treatment options for patients at risk of blood clots.
Nordica Medica Sp. z o.o in Sopot, Poland, supports a focused research program with a single investigator overseeing two active trials.
Clinical trials currently enrolling participants at this site.
Safety and Pharmacodynamic Study of Subcutaneous RBD1119 in Adults with Coronary Artery Disease
PolandSafety, Tolerability and Effect of RBD4059 Injection in Adults with Prior VTE After Anticoagulant Therapy and Cancer Patients at High Risk of VTE
PolandGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
